Compare Lustrum:TAIKO PHARMACEUTICAL CO.,LTD.:4574

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index TAIKO PHARMACEUTICAL CO.,LTD. Go to web site 4574 Medicals 東証プライム December 1, 2000 2009.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020
Cash and Cash Equivalents
(Percent)
5,484up
(41.5%)up
3,105down
(20.6%)down
5,796up
(25.7%)up
4,945down
(15.6%)down
9,906
(38.9%)
Other Current AssetsHelp
(Percent)
3,625down
(27.4%)down
4,451down
(29.6%)down
7,987down
(35.4%)down
14,877up
(46.8%)up
6,678
(26.2%)
Tangible Fixed AssetsHelp
(Percent)
3,581down
(27.1%)down
6,397down
(42.5%)up
7,113down
(31.6%)up
9,447up
(29.7%)up
7,108
(27.9%)
Intangible Fixed AssetHelp
(Percent)
1down
(0.0%)down
222down
(1.5%)up
299down
(1.3%)up
319up
(1.0%)up
220
(0.9%)
Investments and OthersHelp
(Percent)
529down
(4.0%)down
871down
(5.8%)down
1,340down
(5.9%)down
2,170up
(6.8%)up
1,561
(6.1%)
Total AssetsHelp
(Percent)
13,220
(100%)
15,046
(100%)
22,535
(100%)
31,758
(100%)
25,474
(100%)
Total Current LiabilitiesHelp
(Percent)
4,460up
(33.7%)up
4,261down
(28.3%)up
5,914down
(26.2%)down
8,913up
(28.1%)up
6,048
(23.7%)
Total Long-term LiabilitiesHelp
(Percent)
2,021down
(15.3%)down
2,741down
(18.2%)up
3,814up
(16.9%)up
64up
(0.2%)down
52
(0.2%)
Shareholder's EquityHelp
(Percent)
6,739down
(51.0%)down
8,044down
(53.5%)down
12,807down
(56.8%)down
22,781up
(71.7%)down
19,374
(76.1%)
Total LiabilitiesHelp
(Percent)
13,220
(100%)
15,046
(100%)
22,535
(100%)
31,758
(100%)
25,474
(100%)

TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020
Amount of Sales
(Percent)
6,120
(100%)
5,040
(100%)
11,299
(100%)
17,583
(100%)
14,966
(100%)
Total Sales
(Percent)
6,120
(100%)
5,040
(100%)
11,299
(100%)
17,583
(100%)
14,966
(100%)
Cost of SalesHelp
(Percent)
3,543down
(57.9%)down
3,961down
(78.6%)up
7,973up
(70.6%)up
5,263up
(29.9%)up
4,358
(29.1%)
Other Costs and RevenueHelp 6,187up
(101.1%)down
5,973down
(118.5%)up
12,919up
(114.3%)up
8,468up
(48.2%)down
8,155
(54.5%)
Total CostsHelp 9,730 9,934 20,892 13,731 12,513
Net RevenueHelp 2,577up
(42.1%)up
1,079down
(21.4%)down
3,326down
(29.4%)down
12,320up
(70.1%)down
10,608
(70.9%)
Earnings Before TaxHelp -3,563up
(-58.2%)up
-4,869up
(-96.6%)down
-8,887down
(-78.7%)down
5,374up
(30.6%)up
3,504
(23.4%)
Net IncomeHelp -3,610up
(-59.0%)up
-4,894up
(-97.1%)down
-9,593down
(-84.9%)down
3,852up
(21.9%)up
2,453
(16.4%)
当期純利益 -3,610 -4,894 -9,593 3,852 2,453

TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年12月期 TAIKO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
-307up
(-11.1%)up
-1,993down
(-66.7%)down
-1,596down
(-39.5%)down
-1,517down
(-30.7%)down
3,493
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
1,166up
(42.3%)up
190up
(6.4%)up
-1,622up
(-40.1%)up
-2,760down
(-55.8%)down
-448
(-12.8%)
Financing Cash FlowHelp
(Percent)
1,539up
(55.9%)up
-997down
(-33.3%)down
3,959up
(98.0%)up
-649down
(-13.1%)up
-581
(-16.6%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
49down
(1.8%)down
76down
(2.5%)up
82up
(2.0%)up
-22down
(-0.4%)down
-10
(-0.3%)
Net Increase and Decrease in Cash and Cash Equivalentsn 2,447up
(88.9%)up
-2,724down
(-91.1%)down
823up
(20.4%)up
-4,948down
(-100.0%)down
2,453
(70.2%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

TAIKO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

Modalis Therapeutics Corporation
NANO MRNA Co., Ltd.
Eisai Co.,Ltd.
Otsuka Holdings Co.,Ltd.
SEIKAGAKU CORPORATION
Mitsubishi Tanabe Pharma Corporation
ZERIA PHARMACEUTICAL CO.,LTD.
Immuno-Biological Laboratories Co., Ltd.
Sumitomo Pharma Co., Ltd.
SAWAI GROUP HOLDINGS Co., Ltd.